Cover Image
Market Research Report
Product code 

Arthroscopy Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Published: | Mordor Intelligence Pvt Ltd | 116 Pages | Delivery time: 2-3 business days


Back to Top
Arthroscopy Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
Published: January 17, 2022
Mordor Intelligence Pvt Ltd
Content info: 116 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents

The arthroscopy devices market is expected to witness a CAGR of 6%, during the forecast period. Certain factors that are driving the market growth include increasing incidences of sports injuries, rising geriatric population, and technological advancements in arthroscopic implants.

Fractures, strains, sprains, and dislocations are the most common sports injuries. The usual self-treatment recommended for these injuries includes rest, ice, compression, and elevation (RICE). For serious injuries that need more attention, an arthroscopy could be recommended, depending on the situation. Injuries can occur in various places and can be of various types. Some of the common injuries include shoulder, hip, knee, elbow, wrist, or ankle injuries; cartilage tears or ligament injuries; inflammation of the lining of the joints; removal of loose fragments of bone or cartilage that become lodged in a joint; and osteoarthritis caused by cartilage loss in a joint. Some of these may require arthroscopic surgery, as it is helpful in their diagnosis and treatment.

According to the US Centers for Disease Control (CDC), participation in organized sports is increasing. Each year, approximately 30 million children and adolescents participate in youth sports in the United States. Out of them, athletes from high schools account for an estimated 2 million injuries, 0.5 million doctor visits, and 30,000 hospitalizations, every year. Moreover, more than 3.5 million kids under the age of 14 years receive medical treatment for sports injuries, every year. Children between the age of 5-14 years account for nearly 40% of all sports injuries treated in hospitals. In the United States, injuries associated with participation in sports and recreational activities accounted for 21% of all traumatic brain injuries among children, in 2017. The above-mentioned statistics exhibit an increased number of injuries that require arthroscopy procedures, which is expected to have a positive impact on the market studied.

However, the average standard cost of an outpatient treatment using arthroscopic surgery for complicated tears can cost about USD 7,400-9,000, or even more, depending on the age of the patient, the severity and exact location of the injury, the related injuries, and on the hospital where the procedure is performed. The Agency for Healthcare Research and Quality sponsors a series of medical databases. One such database, namely, Healthcare Cost and Utilization, shows that an outpatient arthroscopic surgery typically costs USD 8,970. For insured patients, out-of-pocket costs typically consist of a specialist co-pay, i.e., mostly a hospital copay of USD 100 or more, and coinsurance of 10-50% for the procedure, which could reach the yearly out-of-pocket maximum. According to the Kaiser Family Foundation, the average hospital copay is USD 132 for outpatient surgery, and USD 232 for inpatient surgery, and the average coinsurance rate is 17-18%. This shows that the average cost of arthroscopic procedures is very high, which could lead to people not opting for the procedure. Hence, high cost proves to be a potential restraint for the market.

Key Market Trends

Knee Arthroscopy is Expected to Hold Significant Market Share in the Application Segment

Degenerative knee disease is a globally occurring phenomenon among the elderly, which is gaining prevalence due to an increase in the global geriatric population. According to WHO, approximately 25% of the people older than 50 years experience knee pain from degenerative knee disease. The pain is impairing in nature, and often, a knee replacement procedure is the final and only resort to alleviate the pain. Arthroscopic knee surgery for degenerative knee disease is the most common orthopedic procedure in the United States and other developed countries. The demand for knee arthroscopy is increasing globally, due to the increasing prevalence of sports injuries, particularly those acquired in contact sports.

North America Dominates the Market and the Trend is Expected to Continue during the Forecast Period

In the past two decades, there has been a drastic increase in the number of arthroscopies performed in North America. Knee arthroscopy and hip arthroscopy witnessed the highest growth. According to estimates derived from the Humana Claims database, the number of hip arthroscopies witnessed a very high growth rate, from 2007 to 2014. The highest incidence was registered by patients belonging to the age group of 35-44 years. The number of hip arthroscopies performed in North America is continuing to increase, along with an increase in the complexity and diversity of procedures. The diversity of procedures is indicative of the advancements in arthroscopy products and the highly active research ecosystem for arthroscopic applications. The increase in arthroscopy procedures in the region is driven by the increasing prevalence of chronic diseases and orthopedic ailments, especially among the aging population of the region. Additionally, there has been a drastic increase in the prevalence of sports injuries in North America. This is directly correlated to the increased number of arthroscopy procedures that are being performed in the region.

Competitive Landscape

The arthroscopy devices market is highly competitive and consists of a number of major players. Companies, like Arthrex Inc., Conmed Corporation, Johnson & Johnson (DePuy Synthes), Karl Storz GmbH & Co. KG, Medtronic PLC, Richard Wolf GmbH, Smith & Nephew PLC, and Stryker Corporation, among others, hold the substantial share in the market studied.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Product Code: 57113



  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study




  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Incidences of Sports Injuries
    • 4.2.2 Rising Geriatric Population
    • 4.2.3 Technological Advancements in Arthroscopic Implants
  • 4.3 Market Restraints
    • 4.3.1 Lack of Skilled Surgeons
    • 4.3.2 Stringent Regulatory Requirements
    • 4.3.3 High Cost of Arthroscopy Devices
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry


  • 5.1 Application
    • 5.1.1 Knee Arthroscopy
    • 5.1.2 Hip Arthroscopy
    • 5.1.3 Spine Arthroscopy
    • 5.1.4 Shoulder and Elbow Arthroscopy
    • 5.1.5 Other Arthroscopy Applications
  • 5.2 Product
    • 5.2.1 Arthroscope
    • 5.2.2 Arthroscopic Implant
    • 5.2.3 Fluid Management System
    • 5.2.4 Radiofrequency (RF) System
    • 5.2.5 Visualization System
    • 5.2.6 Other Products
  • 5.3 Geography
    • 5.3.1 North America
      • United States
      • Canada
      • Mexico
    • 5.3.2 Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Rest of Europe
    • 5.3.3 Asia-Pacific
      • China
      • Japan
      • India
      • Australia
      • South korea
      • Rest of Asia-Pacific
    • 5.3.4 Middle-East & Africa
      • GCC
      • South Africa
      • Rest of Middle-East & Africa
    • 5.3.5 South America
      • Brazil
      • Argentina
      • Rest of South America


  • 6.1 Company Profiles
    • 6.1.1 Arthrex Inc.
    • 6.1.2 Conmed Corporation
    • 6.1.3 Johnson & Johnson
    • 6.1.4 Karl Storz GmbH & Co. KG
    • 6.1.5 Medtronic PLC
    • 6.1.6 Richard Wolf GmbH
    • 6.1.7 Smith & Nephew PLC
    • 6.1.8 Stryker Corporation